Furniture Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Furniture Press Releases.

Press releases published on August 4, 2026

Aug. 4, 2026

NIOB cuts target pegmatite in all Bardy holes

Indeterminate GlobeNewswire

Aug. 4, 2026

3D Systems Announces CEO Transition Plan

Indeterminate GlobeNewswire

Aug. 4, 2026

Palvella Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire

Aug. 4, 2026

Harmony Biosciences Announces Record Q2 2026 Revenue and Shares Initial Clinical Data for Its Orexin-2 Agonist BP-205 Reinforcing Potential Best-in-Class Profile

Indeterminate GlobeNewswire

Aug. 4, 2026

Volatus Aerospace Partners with Singular Aircraft to Introduce Heavy-Lift Autonomous Aircraft for Canadian Wildfire Response

Indeterminate GlobeNewswire

Aug. 4, 2026

Volatus Aerospace s'associe à Singular Aircraft pour lancer un aéronef autonome de transport lourd destiné à la lutte contre les feux de forêt au Canada

Indeterminate GlobeNewswire

Aug. 4, 2026

Abaxx Exchange Monthly Trading Volume More Than Doubles in July 2026

Indeterminate GlobeNewswire

Aug. 4, 2026

Dyadic Expands Commercial Non-Animal Dairy Pipeline Through New Strategic Development Agreement

Indeterminate GlobeNewswire

Aug. 4, 2026

The Smurfs Have Arrived in Talking Tom & Friends: World

Indeterminate GlobeNewswire

Aug. 4, 2026

LEPAS Builds New Momentum in July, Advancing Global NEV Expansion

Indeterminate GlobeNewswire

Aug. 4, 2026

Microchip Technology, in Collaboration With Micron Technology, Demonstrates High-Performance PCIe® Gen 6 Storage Architecture for AI and Data Center Infrastructure

Indeterminate GlobeNewswire

Aug. 4, 2026

Xometry Reports Record Second Quarter 2026 Results

Indeterminate GlobeNewswire

Aug. 4, 2026

Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 

Indeterminate GlobeNewswire

Aug. 4, 2026

Rhythm Pharmaceuticals Reports Second Quarter 2026 Financial Results and Business Update

Indeterminate GlobeNewswire

Aug. 4, 2026

Oblenio Announces First Patients Dosed in Innovative Phase 1a Trial of LBL-051 in Refractory Autoimmune Diseases

Indeterminate GlobeNewswire

Aug. 4, 2026

Remix Therapeutics to Present at 46th Annual Canaccord Genuity Growth Conference

Indeterminate GlobeNewswire

Aug. 4, 2026

Descartes Sets Date to Announce Second Quarter Fiscal 2027 Financial Results

Indeterminate GlobeNewswire

Aug. 4, 2026

Aclarion Announces Nociscan® Now Available at Goodman Campbell Brain & Spine at Ascension St. Vincent, First Site in Indiana to Offer the Technology

Indeterminate GlobeNewswire

Aug. 4, 2026

NeurAxis Expands Payer Coverage with New Policies

Indeterminate GlobeNewswire

Aug. 4, 2026

Larimar Therapeutics Reports Second Quarter 2026 Financial and Business Update

Indeterminate GlobeNewswire